The State of Overmedication in Borderline Personality Disorder: Interpersonal and Structural Factors
- PMID: 36185615
- PMCID: PMC9524237
- DOI: 10.1007/s40501-021-00255-x
The State of Overmedication in Borderline Personality Disorder: Interpersonal and Structural Factors
Abstract
Purpose of review: a)This review paper describes the state of prescribing practice in Borderline Personality Disorder (BPD), wherein medications are prescribed far more than either evidence or practice guideline would recommend. First, we describe the frequencies of medication use and polypharmacy in people with BPD.
Recent findings: b)In subsequent sections, we elaborate two main categories of factors that lead to overmedication of people with BPD: the interpersonally mediated and the structural. We consider interpersonally mediated factors to arise from communications of patients in distress and the well-meaning efforts of their prescribers to provide relief for certain overwhelming affective states. We are particularly focused on patterns of countertransference in prescribing that are directly linked to specific aspects of BPD pathology. We consider structural factors to arise from the complexities of medical and medicolegal systems and the contemporary patterns of financing medical care; we postulate that these complexities often compel prescribers to start medications, with associated disincentives for decreasing or discontinuing those medications over time.
Summary: c)More research is needed to understand how to best use medications in BPD, for example in targeted combination with psychotherapeutic and psychosocial interventions. However, current practice often departs markedly from the evidence. We recommend the dissemination of accessible, generalist BPD-treatment models in outpatient and inpatient practice; increased early detection of BPD; and increased diagnostic disclosure. We also recommend for individual providers and systems to implement prospective treatment plans that draw from BPD-specific psychosocial models. This approach can employ tiers of interventions to minimize reactive prescribing by anticipating high affect and offering BPD patients steadily empathic evidence-supported care.
Keywords: Borderline Personality Disorder; Good Psychiatric Management; countertransference; deprescribing; psychopharmacology; psychotropics.
Conflict of interest statement
Declarations The authors declare no conflicts of interest and no competing interests.
Similar articles
-
Factors That Influence Prescribing in Borderline Personality Disorder: A Systematic Review.Personal Ment Health. 2025 May;19(2):e70014. doi: 10.1002/pmh.70014. Personal Ment Health. 2025. PMID: 40010400 Free PMC article.
-
Collaborative Deprescribing in Borderline Personality Disorder: A Narrative Review.Harv Rev Psychiatry. 2019 Mar/Apr;27(2):75-86. doi: 10.1097/HRP.0000000000000200. Harv Rev Psychiatry. 2019. PMID: 30676404 Review.
-
Pharmacotherapy of borderline personality disorder: replacing confusion with prudent pragmatism.Curr Opin Psychiatry. 2018 Jan;31(1):69-73. doi: 10.1097/YCO.0000000000000373. Curr Opin Psychiatry. 2018. PMID: 29028643 Review.
-
Psychopharmacological treatment of patients with borderline personality disorder: comparing data from routine clinical care with recommended guidelines.Int J Psychiatry Clin Pract. 2019 Sep;23(3):178-188. doi: 10.1080/13651501.2019.1576904. Epub 2019 May 29. Int J Psychiatry Clin Pract. 2019. PMID: 31140337
-
[Borderline personality disorder, self-mutilation and suicide: literature review].Encephale. 2008 Oct;34(5):452-8. doi: 10.1016/j.encep.2007.10.007. Epub 2008 Feb 20. Encephale. 2008. PMID: 19068333 Review. French.
Cited by
-
Trends in pharmacological prescriptions and polypharmacy for personality disorders: a 10-year cross-sectional analysis of naturalistic data.BMC Psychiatry. 2025 Apr 1;25(1):314. doi: 10.1186/s12888-025-06716-4. BMC Psychiatry. 2025. PMID: 40170029 Free PMC article.
-
Borderline Personality Disorder: A Comprehensive Review of Current Diagnostic Practices, Treatment Modalities, and Key Controversies.Cureus. 2024 Dec 17;16(12):e75893. doi: 10.7759/cureus.75893. eCollection 2024 Dec. Cureus. 2024. PMID: 39822482 Free PMC article. Review.
-
Characterizing psychopharmacological prescribing practices in a large cohort of adolescents with borderline personality disorder.Borderline Personal Disord Emot Dysregul. 2024 Aug 6;11(1):17. doi: 10.1186/s40479-024-00262-3. Borderline Personal Disord Emot Dysregul. 2024. PMID: 39103898 Free PMC article.
-
Factors That Influence Prescribing in Borderline Personality Disorder: A Systematic Review.Personal Ment Health. 2025 May;19(2):e70014. doi: 10.1002/pmh.70014. Personal Ment Health. 2025. PMID: 40010400 Free PMC article.
-
Why do patients want medication free treatment for psychosis? An explorative study on reasons for applying to medication free programs.BMC Psychiatry. 2024 Feb 16;24(1):127. doi: 10.1186/s12888-024-05513-9. BMC Psychiatry. 2024. PMID: 38365662 Free PMC article.
References
-
- Linehan MMJJoPd. Dialectical behavioral therapy: A cognitive behavioral approach to parasuicide. 1987;1(4):328–33.
-
- Doering S, Hörz S, Rentrop M, Fischer-Kern M, Schuster P, Benecke C et al. Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial. 2010;196(5):389–95. - PubMed
-
- Bateman AW, Fonagy PJJopd. Mentalization-based treatment of BPD. 2004;18(1):36–51. - PubMed
-
- Gunderson J, Masland S, Choi-Kain LJCoip. Good psychiatric management: a review. 2018;21:127–31. - PubMed
-
· · Reviews evidence of GPM as an effective generalist model for BPD
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials